Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2025-05-12 00:00:00 ET · period of report 2025-05-08 · accession 0001808805-25-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-12 | 2025-05-08+ | NAUT | Mallick Parag | Chief Scientist, Dir, 10% | P - Purchase | $0.73 | +13.5K | 20.49M | +0.1% | +$9,855 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | P | A | 1,500 | $0.73 | 20,493,392 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2025-05-08 | P | A | 12,000 | $0.73 | 20,491,892 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |